Exact Sciences Corp (EXAS) Posts Q2 Loss of 24c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Exact Sciences (EXAS) PT Bumped at Jefferies Post Q2
July 23, 2014 8:55 AM EDTJefferies analyst Brandon Couillard raised his price target but lowered estimates on Buy-rated Exact Sciences (NASDAQ: EXAS) following Q2 results.
Couillard comments, "EXAS' 2Q14 earnings call served as a forum for it to provide an update on the anticipated timing of upcoming FDA &... More
